DexCom Inc. (DXCM)
Health Care4 articles
Price chart
DexCom Inc. (DXCM) overview
DexCom makes continuous glucose-monitoring systems for diabetes. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.
DexCom Inc. trades on the NasdaqGS under the ticker symbol DXCM. As of the most recent market data, the stock was priced around $76.65, down 1.71% on the session, giving DexCom Inc. a market capitalization of roughly $29.58B.
Over the past 52 weeks, DXCM has traded between $54.11 and $89.98. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 33.5, a common gauge of how richly the market prices the company's earnings.
Key statistics
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch DXCM
As one of the larger companies in the Health Care sector, DexCom Inc. is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch DXCM for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.
Market Mood
Latest DXCM news
Deutsche Bank Lists Healthcare Stocks DexCom (DXCM), Insulet (PODD)
Deutsche Bank has identified DexCom (DXCM) and Insulet (PODD) as top healthcare stocks for investors. The bank noted various factors, including growth potential and market trends, that could influence these companies' performances. Specific target prices and earnings projections were not disclosed in the article. This report may affect investor sentiment towards the healthcare sector, particularly for stocks within this category.
Read More: Deutsche Bank Lists Healthcare Stocks DexCom (DXCM), Insulet (PODD)
DEXCOM (DXCM) Files Form 144 on May 15, 2023
On May 15, 2023, Dexcom (DXCM) filed a Form 144 with the SEC. This form is typically used to notify the SEC of a proposed sale of stock by an affiliate. The specific details regarding the number of shares to be sold or the price were not disclosed. Such filings can indicate potential changes in stock ownership that may impact market perceptions and trading activity.
Read More: DEXCOM (DXCM) Files Form 144 on May 15, 2023
DexCom (DXCM) Trading at $64.62 with P/E Ratios 30.92 and 25.91
DexCom, Inc. (DXCM) shares traded at $64.62 as of April 20th. The company reported trailing and forward P/E ratios of 30.92 and 25.91, respectively. DexCom has achieved an average revenue growth of 17.4% annually over the past three years, with projections suggesting 15.2% growth ahead. The launch of the Stelo over-the-counter CGM and the G7 15-day sensor is expected to expand the market and improve gross margins to 63-64%, potentially increasing user retention and capturing millions of new insured lives. DexCom is targeting aggressive growth in international markets, particularly in Western Europe, Japan, and Australia.
Read More: DexCom (DXCM) Trading at $64.62 with P/E Ratios 30.92 and 25.91
Dexcom (DXCM) EVP Brown Sells $107K in Shares
Dexcom's (DXCM) Executive Vice President, Brown, sold shares worth $107,000. This transaction may raise questions among investors about future company performance and insider sentiment. Typically, large insider sales can influence market perception regarding the stock, particularly if there are no accompanying positive developments. The timing and context of such sales can also impact trading volumes and market reactions.
Read More: Dexcom (DXCM) EVP Brown Sells $107K in SharesMore Health Care stocks
Frequently asked questions
Is DexCom Inc. in the S&P 500?
Yes. DexCom Inc. (DXCM) is a member of the S&P 500 index, classified in the Health Care sector.
What sector is DXCM in?
DexCom Inc. is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.
Where can I find the latest DXCM news?
This page collects recent DexCom Inc. (DXCM) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.
What is DexCom Inc.'s stock price?
As of the most recent market data, DexCom Inc. (DXCM) traded at approximately $76.65. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.
What is DexCom Inc.'s market cap?
DexCom Inc. has a market capitalization of roughly $29.58B, based on its most recent share price and shares outstanding.
What is DXCM's P/E ratio?
DXCM trades at a trailing price-to-earnings ratio of about 33.5. The P/E ratio compares a company's share price to its earnings per share.